Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update

J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):386-8. doi: 10.1097/mpg.0b013e3181957a11.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adalimumab
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Drug Therapy, Combination
  • Female
  • Humans
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab
  • Liver Neoplasms / chemically induced*
  • Lymphoma, T-Cell / chemically induced*
  • Male
  • Splenic Neoplasms / chemically induced*
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Infliximab
  • Adalimumab